Skip to main content Back to Top
Advertisement

6/26/2019

Rosuvastatin Calcium Tablets

Products Affected - Description

    • Rosuvastatin calcium oral tablet, Accord, 10 mg, bottle, 1,000 count, NDC 16729-0285-17
    • Rosuvastatin calcium oral tablet, Apotex, 10 mg, bottle, 90 count, NDC 60505-4503-09 - discontinued
    • Rosuvastatin calcium oral tablet, Apotex, 20 mg, bottle, 90 count, NDC 60505-4504-09 - discontinued
    • Rosuvastatin calcium oral tablet, Apotex, 40 mg, bottle, 30 count, NDC 60505-4505-03 - discontinued
    • Rosuvastatin calcium oral tablet, Apotex, 5 mg, bottle, 90 count, NDC 60505-4502-09 - discontinued
    • Rosuvastatin calcium oral tablet, Biocon, 40 mg, bottle, 30 count, NDC 70377-0009-11
    • Rosuvastatin calcium oral tablet, Biocon, 40 mg, bottle, 90 count, NDC 70377-0009-12
    • Rosuvastatin calcium oral tablet, Mylan, 10 mg, unit-dose blister pack, 100 count, NDC 42292-0030-20 - discontinued
    • Rosuvastatin calcium oral tablet, Mylan, 5 mg, unit-dose blister pack, 100 count, NDC 42292-0029-20 - discontinued
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 10 mg, bottle, 90 count, NDC 57237-0169-90
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 10 mg, bottle, 1000 count, NDC 57237-0169-99
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 20 mg, bottle, 90 count, NDC 57237-0170-90
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 20 mg, bottle, 1000 count, NDC 57237-0170-99
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 40 mg, bottle, 30 count, NDC 57237-0171-30
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 40 mg, bottle, 90 count, NDC 57237-0171-90
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 40 mg, bottle, 500 count, NDC 57237-0171-05
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 5 mg, bottle, 90 count, NDC 57237-0168-90
    • Rosuvastatin calcium oral tablet, Rising Pharmaceuticals, 5 mg, bottle, 500 count, NDC 57237-0168-05
    • Rosuvastatin calcium oral tablet, Sandoz, 5 mg, bottle, 90 count, NDC 00781-5400-92
    • Rosuvastatin calcium oral tablet, Sun Pharma, 10 mg, bottle, 90 count, NDC 47335-0583-81 - discontinued
    • Rosuvastatin calcium oral tablet, Sun Pharma, 20 mg, bottle, 90 count, NDC 47335-0584-81 - discontinued
    • Rosuvastatin calcium oral tablet, Sun Pharma, 40 mg, bottle, 90 count, NDC 47335-0585-83 - discontinued
    • Rosuvastatin calcium oral tablet, Sun Pharma, 5 mg, bottle, 90 count, NDC 47335-0582-81 - discontinued

Reason for the Shortage

    • Accord, Biocon, Rising, and Sandoz did not provide a reason for the shortage.
    • Apotex has discontinued production of all rosuvastatin presentations.
    • Aurobindo refuses to provide updated availability information.
    • Camber, Glenmark, and Sandoz have rosuvastatin presentations available.
    • Mylan has discontinued all rosuvastatin presentations.
    • Sun Pharma is discontinuing production of all rosuvastatin presentations.

Available Products

    • Crestor oral tablet, AstraZeneca, 10 mg, bottle, 90 count, NDC 00310-0751-90
    • Crestor oral tablet, AstraZeneca, 10 mg, bottle, 100 count, NDC 00310-0751-39
    • Crestor oral tablet, AstraZeneca, 20 mg, bottle, 90 count, NDC 00310-0752-90
    • Crestor oral tablet, AstraZeneca, 40 mg, bottle, 30 count, NDC 00310-0784-30
    • Crestor oral tablet, AstraZeneca, 5 mg, bottle, 90 count, NDC 00310-0755-90
    • Rosuvastatin calcium oral tablet, Accord, 10 mg, bottle, 90 count, NDC 16729-0285-15
    • Rosuvastatin calcium oral tablet, Accord, 20 mg, bottle, 90 count, NDC 16729-0286-15
    • Rosuvastatin calcium oral tablet, Accord, 20 mg, bottle, 1,000 count, NDC 16729-0286-17
    • Rosuvastatin calcium oral tablet, Accord, 40 mg, bottle, 30 count, NDC 16729-0287-10
    • Rosuvastatin calcium oral tablet, Accord, 40 mg, bottle, 90 count, NDC 16729-0287-15
    • Rosuvastatin calcium oral tablet, Accord, 40 mg, bottle, 1,000 count, NDC 16729-0287-17
    • Rosuvastatin calcium oral tablet, Accord, 5 mg, bottle, 90 count, NDC 16729-0284-15
    • Rosuvastatin calcium oral tablet, Accord, 5 mg, bottle, 1,000 count, NDC 16729-0284-17
    • Rosuvastatin calcium oral tablet, Biocon, 10 mg, bottle, 90 count, NDC 70377-0007-12
    • Rosuvastatin calcium oral tablet, Biocon, 20 mg, bottle, 90 count, NDC 70377-0008-12
    • Rosuvastatin calcium oral tablet, Biocon, 5 mg, bottle, 90 count, NDC 70377-0006-12
    • Rosuvastatin calcium oral tablet, Camber, 10 mg, bottle, 90 count, NDC 31722-0883-90
    • Rosuvastatin calcium oral tablet, Camber, 20 mg, bottle, 90 count, NDC 31722-0884-90
    • Rosuvastatin calcium oral tablet, Camber, 40 mg, bottle, 30 count, NDC 31722-0885-30
    • Rosuvastatin calcium oral tablet, Camber, 5 mg, bottle, 90 count, NDC 31722-0882-90
    • Rosuvastatin calcium oral tablet, Glenmark, 10 mg, bottle, 90 count, NDC 68462-0262-90
    • Rosuvastatin calcium oral tablet, Glenmark, 20 mg, bottle, 90 count, NDC 68462-0263-90
    • Rosuvastatin calcium oral tablet, Glenmark, 40 mg, bottle, 30 count, NDC 68462-0264-30
    • Rosuvastatin calcium oral tablet, Glenmark, 5 mg, bottle, 90 count, NDC 68462-0261-90
    • Rosuvastatin calcium oral tablet, Novadoz, 10 mg, bottle, 90 count, NDC 72205-0003-90
    • Rosuvastatin calcium oral tablet, Novadoz, 10 mg, bottle, 1,000 count, NDC 72205-0003-99
    • Rosuvastatin calcium oral tablet, Novadoz, 20 mg, bottle, 90 count, NDC 72205-0004-90
    • Rosuvastatin calcium oral tablet, Novadoz, 20 mg, bottle, 1,000 count, NDC 72205-0004-99
    • Rosuvastatin calcium oral tablet, Novadoz, 40 mg, bottle, 30 count, NDC 72205-0005-30
    • Rosuvastatin calcium oral tablet, Novadoz, 40 mg, bottle, 90 count, NDC 72205-0005-90
    • Rosuvastatin calcium oral tablet, Novadoz, 40 mg, bottle, 1,000 count, NDC 72205-0005-99
    • Rosuvastatin calcium oral tablet, Novadoz, 5 mg, bottle, 90 count, NDC 72205-0002-90
    • Rosuvastatin calcium oral tablet, Novadoz, 5 mg, bottle, 1,000 count, NDC 72205-0002-99
    • Rosuvastatin calcium oral tablet, Sandoz, 10 mg, bottle, 90 count, NDC 00781-5401-92
    • Rosuvastatin calcium oral tablet, Sandoz, 20 mg, bottle, 90 count, NDC 00781-5402-92
    • Rosuvastatin calcium oral tablet, Sandoz, 40 mg, bottle, 30 count, NDC 00781-5403-31
    • Rosuvastatin calcium oral tablet, Torrent, 10 mg, bottle, 30 count, NDC 13668-0180-30
    • Rosuvastatin calcium oral tablet, Torrent, 10 mg, bottle, 90 count, NDC 13668-0180-90
    • Rosuvastatin calcium oral tablet, Torrent, 20 mg, bottle, 30 count, NDC 13668-0181-30
    • Rosuvastatin calcium oral tablet, Torrent, 20 mg, bottle, 90 count, NDC 13668-0181-90
    • Rosuvastatin calcium oral tablet, Torrent, 40 mg, bottle, 30 count, NDC 13668-0182-30
    • Rosuvastatin calcium oral tablet, Torrent, 5 mg, bottle, 30 count, NDC 13668-0179-30
    • Rosuvastatin calcium oral tablet, Torrent, 5 mg, bottle, 90 count, NDC 13668-0179-90

Estimated Resupply Dates

    • Accord has rosuvastatin 10 mg tablets in 1000 count bottles on back order and the company estimates a release date of early- to mid-July 2019.
    • Biocon has rosuvastatin 40 mg tablets in 30 count bottles on back order and the company estimates a release date of early-July 2019.
    • Rising has all rosuvastatin presentations on allocation.
    • Sandoz has rosuvastatin 5 mg tablets in 90 count bottles on back order and the company cannot estimate a release date.

Updated

Updated June 26, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 20, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins